- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05743153
Faisabilité d'un programme d'intervention multimodale pour optimiser les résultats du traitement de la colite ulcéreuse (OPTIMIZE-UC)
OPTIMIZE-UC : Faisabilité d'un programme d'intervention multimodal pour optimiser les résultats du traitement de la colite ulcéreuse : une étude pilote prospective
This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in Ulcerative Colitis (UC) patients with active disease as well as in patients in remission. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Rationale: Despite considerable advances in the knowledge of UC, and a variation of treatment options, UC still impacts patients' ability to lead a normal life. Clearly, there is an unmet need to improve treatment outcomes. Prehabilitation programs in surgery have shown that the amount of complications is closely related to preoperative physical fitness, nutritional status and psychological well-being. IBD patients often search for self-management strategies to manage their symptoms, however, research focussing on a multimodal intervention approach in parallel to starting new IBD treatment is lacking. Given the potential benefits of intervention programs, limitations of current treatments in terms of improving quality of life and patients' desire for self-management options, we believe that exploring the results of a multimodal intervention program in patients with UC is of high relevance.
Objective/study design: This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in UC patients. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.
Study population: Patients ≥ 18 years old, with UC. Intervention: Multimodal intervention program including an exercise program, nutritional intervention and psychological evaluation.
Main study parameters/endpoints: This study assesses the feasibility of a multimodal intervention program. Secondary, assesses the effect on:
- Individual patients' level, i.e. physical fitness, nutritional status, mental health, quality of life and work productivity and activity impairment.
- Therapy outcomes, e.g. adherence, number and severity of (S)AEs, corticosteroid use, biochemical and clinical response/remission rates and patient reported outcomes.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Nijmegen, Pays-Bas, 6525GA
- Dorien Oomkens
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Age ≥ 18 years old;
- Diagnosis of UC confirmed by clinical, endoscopic, and/or histological evidence prior to screening as per standard criteria;
- Ability of subject to participate fully in all aspects of this project;
- Written informed consent must be obtained and documented.
Exclusion Criteria:
- Suspicion of differential diagnosis of CD, indeterminate colitis, ischemic colitis, radiation colitis, diverticular disease associated with colitis, or microscopic colitis;
- Serious underlying disease other than UC that in the opinion of the investigator may interfere with the subject's ability to participate fully in the study or would compromise subject safety (such as history of malignancies, major neurological disorders, certain orthopedic impairments or any unstable, uncontrolled or severe systemic medical disorder);
- History of alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;
- History of psychiatric disorders that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;
- If female, the subject is pregnant or lactating (< 1 year) or intending to become pregnant;
- Immobilized patients who are not able to complete exercise intervention;
- Illiteracy (disability to read and understand Dutch).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Patients with ulcerative colitis
Patients participate in multimodal intervention |
Exercise intervention: combined endurance and resistance training three times a week using workout video's which patients can do at home. Advice to exercise at low-intensity for at least 30 minutes per day. Nutritional intervention: Patients are advised to aim for optimal energy and protein intake (by registered dietician) and to avoid red meat, processed foods and sweetened drinks. Aiming for a mainly plant based diet. Psychological intervention: screening for psychological risk factors and if present, patients are referred to a psychologist for psychological support. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Accrural
Délai: 24 weeks
|
The percentage of approached, eligible participants that are included in the study. |
24 weeks
|
|
Attrition
Délai: 24 weeks
|
The percentage of participants who stopped the program prematurely. |
24 weeks
|
|
Adherence to exercise program
Délai: 24 weeks
|
Frequency of followed trainings |
24 weeks
|
|
Adherence to daily exercise goals
Délai: 24 weeks
|
SQUASH questionnaire |
24 weeks
|
|
Patient satisfaction
Délai: 24 weeks
|
Measured using a patient satisfaction questionnaire |
24 weeks
|
|
Safety and adverse events
Délai: 24 weeks
|
Measured by the number of adverse events occurring during the program |
24 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Oxygen Consumption (VO2 max)
Délai: 1 year
|
Indication of physical fitness |
1 year
|
|
Change in 1 repitition measures
Délai: 1 year
|
Indication of muscle strength |
1 year
|
|
Change in body weight
Délai: 1 year
|
Measured in kilograms |
1 year
|
|
Change in fat-free mass
Délai: 1 year
|
Measured with bioelectrical impedance analysis (BIA) |
1 year
|
|
Change in nutritional status
Délai: 1 year
|
Measured with Patient Generated Subjective Global Assessment (PG-SGA) |
1 year
|
|
Change in mental health
Délai: 1 year
|
Hospital Anxiety and Depression scale (HADS questionnaire) |
1 year
|
|
Change in Work Productivity and Activity Impairment
Délai: 1 year
|
Work Productivity and Activity Impairment Questionnaire (including WPAI-GH) |
1 year
|
|
Change in 36-Item Short Form Health Survey (SF-36) score
Délai: 1 year
|
Quality of life |
1 year
|
|
Change in EuroQoL (EQ-5D-5L) score
Délai: 1 year
|
Quality of life |
1 year
|
|
Change in Inflammatory Bowel Disease Questionnaire score
Délai: 1 year
|
Disease-related quality of life |
1 year
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 114110
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .